Recombinant DNA technology: clinical prospects
Moudgil, K.D.
Indian Pediatrics 23(7): 489-492
1986
ISSN/ISBN: 0019-6061 PMID: 3462122 Document Number: 283096
Document emailed within 1 workday
Related Documents
Slavkin, H.C. 1989: Recombinant DNA technology and clinical dentistry International Journal of Prosthodontics 2(1): 80-96Yamamura, K. 1985: Application of recombinant DNA technology to clinical medicine Rinsho Byori. Japanese Journal of Clinical Pathology 33(5): 545-549
Holloway, C.J. 1994: Applications of recombinant DNA technology in the production of glycosylated recombinant human granulocyte colony stimulating factor European Journal of Cancer 30a Suppl 3: S2-S6
Li, C.-t. 2004: Progress and prospects of HLA genotyping technology Fa Yi Xue Za Zhi 20(2): 120-123
Van Wezel, A.L. 1983: Microcarrier technology. Present status and prospects Developments in Biological Standardization 55: 3-9
Szomolányi, E.; Nász, I. 1984: Recombinant DNA technology in adenovirus research Acta Virologica 28(1): 84-92
Heinrich, H.W. 1990: Recombinant virus vaccines--present status and future prospects Archiv für Experimentelle Veterinarmedizin 44(6): 849-853
Hwang, C.; Sanda, M.G. 1999: Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy Current Opinion in Molecular Therapeutics 1(4): 471-479
Elsbach, P.; Weiss, J. 1995: Prospects for use of recombinant BPi in the treatment of gram-negative bacterial infections Infectious Agents and Disease 4(2): 102-109
Ranasinghe, L. 1983: Recombinant technology in medical research and therapeutics Ceylon Medical Journal 28(2): 57-61
Tsuchiya, S.; Maruyama, Y. 1985: New technology and prospects in the field of cytodiagnosis. A. Electron microscopy findings Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 64: 107-129
Korwek, E.L. 1981: OSHA regulation of industrial applications of recombinant DNA technology University of Cincinnati Law Review. University of Cincinnati. College of Law 50(2): 284-313
Asturias, J.A.; Arilla, M.C.; Gómez-Bayón, N.; Martínez, A.; Martínez, J.; Palacios, R. 1997: Recombinant DNA technology in allergology: cloning and expression of plant profilins Allergologia et Immunopathologia 25(3): 127-134
Dallman, P.R. 1993: Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin Advances in Pediatrics 40: 385-403
Generozov, E.V.; Riabov, E.B.; Konareva, T.N.; Arshava, N.V.; Uzbekova, S.V.; Zavriev, S.K. 1996: Preparation of recombinant envelope proteins from spherical phytoviruses and study of prospects for using them for immunoenzyme diagnosis Molekuliarnaia Biologiia 30(2): 461-469
Briseid, G.; Arntzen, F.C. 1995: Factor VIIi preparation produced by recombinant DNA-technology is approved in Norway Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(15): 1849-1851
Miller, H.I. 1982: Recombinant DNA as a paradigm of a new technology: its impact on regulation by the Food and Drug Administration Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 36(6): 248-250
Mock, K. 1993: Routine sensitive peptide mapping using LC/MS of therapeutic proteins produced by recombinant DNA technology Peptide Research 6(2): 100-104
Hilleman, M.R.; Gerety, R.J.; Ellis, R.W. 1987: Concerns for the use of continuous cell lines and certain promoters for producing vaccine antigens by recombinant technology Developments in Biological Standardization 68: 5-7
Jørgensen, M.S.; Jørgensen, U. 2009: Green technology foresight of high technology: a social shaping of technology approach to the analysis of hopes and hypes Technology Analysis-Strategic Management 21(3): 363-379